Pressure BioSciences (PBIO) Stock Chart & Stock Price History → Elon Musk’s Controversial New Project: “Apollo” (From InvestorPlace) (Ad) Free PBIO Stock Alerts $0.25 +0.01 (+4.17%) (As of 04/23/2024 ET) Add Compare Share Share ChartStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest Pressure BioSciences Stock Price Performance5 Day Performance-2.34%1 Month Performance+56.25%3 Month Performance-19.35%6 Month Performance-66.67%Year-To-Date Performance-24.24%1 Year Performance-74.62% Receive PBIO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Pressure BioSciences and its competitors with MarketBeat's FREE daily newsletter Email Address Ad InvestorPlaceElon Musk’s Controversial New Project: “Apollo”Have you seen this footage outside the headquarters of Elon Musk's "Project Apollo?" Big Tech and the mainstream media have called this project "controversial"...Click here to see the details because there's a lot of money at stake. PBIO Stock Chart for Wednesday, April, 24, 2024 PBIO Chart by TradingView Pressure BioSciences Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/23/2024$0.25$0.25$0.25$0.255,200 shs$8.45 million04/22/2024$0.26$0.25-4.30%$0.28$0.2332,500 shs$8.45 million04/19/2024$0.27$0.26-5.08%$0.29$0.2433,300 shs$8.83 million04/18/2024$0.27$0.27$0.27$0.2337,160 shs$9.30 million04/17/2024$0.25$0.27+7.88%$0.27$0.2415,107 shs$9.30 million04/16/2024$0.27$0.25-7.30%$0.25$0.2442,500 shs$8.55 million Get the Latest News and Ratings for PBIO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Pressure BioSciences and its competitors with MarketBeat's FREE daily newsletter. 04/15/2024$0.30$0.27-9.04%$0.29$0.2440,245 shs$9.22 million04/12/2024$0.29$0.30+0.54%$0.31$0.2638,020 shs$10.14 million04/11/2024$0.22$0.29+34.05%$0.30$0.2170,093 shs$10.08 million04/10/2024$0.23$0.22-4.35%$0.24$0.2235,970 shs$7.52 million04/09/2024$0.25$0.23-8.04%$0.24$0.21140,314 shs$7.49 million04/08/2024$0.26$0.25-5.59%$0.28$0.2517,761 shs$8.15 million04/05/2024$0.26$0.25-5.59%$0.28$0.2232,293 shs$8.15 million04/04/2024$0.25$0.26+5.12%$0.27$0.2215,670 shs$8.58 million04/03/2024$0.20$0.25+26.00%$0.27$0.2018,800 shs$8.10 million04/02/2024$0.17$0.20+17.65%$0.21$0.1742,427 shs$6.31 million04/01/2024$0.18$0.17-2.97%$0.19$0.1796,720 shs$5.36 million03/29/2024$0.18$0.18$0.18$0.1757,634 shs$5.53 million03/28/2024$0.16$0.18+13.03%$0.18$0.1757,634 shs$5.44 million03/27/2024$0.16$0.16-0.26%$0.17$0.15163,749 shs$4.81 million03/26/2024$0.16$0.16+0.26%$0.17$0.1628,735 shs$4.83 million03/25/2024$0.16$0.16-3.13%$0.19$0.1680,580 shs$4.81 million03/22/2024$0.18$0.16-9.60%$0.19$0.16109,949 shs$4.69 million03/21/2024$0.16$0.18+14.19%$0.21$0.17149,412 shs$5.19 million03/20/2024$0.14$0.16+7.94%$0.17$0.14661,744 shs$4.54 million03/19/2024$0.17$0.14-13.49%$0.17$0.14409,967 shs$3.94 million03/18/2024$0.18$0.17-6.74%$0.19$0.16101,465 shs$4.55 million03/15/2024$0.18$0.18-1.11%$0.19$0.1765,594 shs$4.88 million03/14/2024$0.19$0.18-2.81%$0.19$0.1730,453 shs$4.89 million03/13/2024$0.20$0.19-7.40%$0.19$0.1817,450 shs$5.03 million03/12/2024$0.20$0.20$0.20$0.1916,950 shs$5.43 million03/11/2024$0.19$0.20+5.32%$0.21$0.1942,350 shs$5.43 million03/08/2024$0.17$0.19+11.57%$0.19$0.17106,645 shs$5.05 million03/07/2024$0.18$0.17-5.44%$0.19$0.15260,320 shs$4.53 million03/06/2024$0.19$0.18-5.26%$0.20$0.17191,024 shs$4.78 million03/05/2024$0.20$0.19-4.90%$0.19$0.1891,370 shs$5.04 million03/04/2024$0.19$0.20+5.16%$0.20$0.17114,044 shs$5.30 million03/01/2024$0.20$0.19-7.27%$0.20$0.17174,986 shs$4.89 million02/29/2024$0.21$0.20-0.05%$0.21$0.18155,262 shs$5.27 million02/28/2024$0.19$0.21+7.89%$0.21$0.1868,989 shs$5.28 millionElon Musk’s Controversial New Project: “Apollo” (Ad)Have you seen this footage outside the headquarters of Elon Musk's "Project Apollo?" Big Tech and the mainstream media have called this project "controversial"...Click here to see the details because there's a lot of money at stake.02/27/2024$0.20$0.19-3.31%$0.21$0.17174,222 shs$4.89 million02/26/2024$0.23$0.20-14.57%$0.23$0.19194,541 shs$5.06 million02/23/2024$0.23$0.23-1.50%$0.23$0.1935,090 shs$5.91 million02/22/2024$0.23$0.23-0.09%$0.23$0.19138,652 shs$6.00 million02/21/2024$0.23$0.23$0.23$0.2094,240 shs$6.01 million02/20/2024$0.25$0.23-4.61%$0.24$0.20113,133 shs$6.01 million02/19/2024$0.25$0.25$0.25$0.2434,400 shs$6.30 million02/16/2024$0.25$0.25$0.25$0.2434,435 shs$6.30 million02/15/2024$0.25$0.25-2.00%$0.29$0.2288,385 shs$6.30 million02/14/2024$0.25$0.25$0.25$0.2471,888 shs$6.43 million02/13/2024$0.28$0.25-10.71%$0.27$0.24150,925 shs$6.40 million02/12/2024$0.28$0.28+0.18%$0.28$0.2449,470 shs$7.16 million02/09/2024$0.29$0.28-3.62%$0.30$0.2736,795 shs$7.11 million02/08/2024$0.33$0.29-13.41%$0.33$0.2996,015 shs$7.38 million02/07/2024$0.34$0.33-1.50%$0.34$0.3027,090 shs$8.52 million02/06/2024$0.30$0.34+13.33%$0.36$0.30103,480 shs$8.65 million02/05/2024$0.32$0.30-6.25%$0.38$0.2956,683 shs$7.64 million02/02/2024$0.30$0.32+6.67%$0.36$0.3228,005 shs$8.14 million02/01/2024$0.26$0.30+17.65%$0.32$0.2639,221 shs$7.64 million01/31/2024$0.26$0.26-1.92%$0.26$0.2424,450 shs$6.49 million01/30/2024$0.30$0.26-13.33%$0.29$0.2585,785 shs$6.62 million01/29/2024$0.30$0.30+0.05%$0.30$0.2875,380 shs$7.64 million01/26/2024$0.34$0.30-11.68%$0.32$0.2863,305 shs$7.63 million01/25/2024$0.31$0.34+9.52%$0.36$0.2837,622 shs$8.64 million01/24/2024$0.32$0.31-1.90%$0.32$0.3068,905 shs$7.88 million01/23/2024$0.38$0.32-16.84%$0.38$0.27324,163 shs$7.46 million Related Companies: Telesis Bio Stock Chart Talis Biomedical Stock Chart Accelerate Diagnostics Stock Chart Singular Genomics Systems Stock Chart Cyclerion Therapeutics Stock Chart Glucose Health Stock Chart TRxADE HEALTH Stock Chart Virios Therapeutics Stock Chart Vapotherm Stock Chart Intelligent Bio Solutions Stock Chart Receive PBIO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Pressure BioSciences and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:PBIO) was last updated on 4/24/2024 by MarketBeat.com Staff From Our Partnerstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencySHOCKING Crypto Leak…Crypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingMan Who Predicted 2008: “This Will be Worse.”AltimetryBiden out June 13; Kamala won’t replace him?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pressure BioSciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.